Leonardo DRS (DRS) vs Regal Rexnord (RRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Regal Rexnord (RRX) has outperformed Leonardo DRS (DRS) over the past year, gaining 14.0% versus a loss of 20.0%. Over five years, DRS leads with a +248.4% price change compared with +13.8% for RRX. Regal Rexnord is the larger company by market cap ($10.93 billion vs $9.55 billion), about 1.1 times the size, while Leonardo DRS is growing revenue faster (+12.8% vs -1.6%).
On valuation, Regal Rexnord trades at a lower forward P/E (12.6x vs 24.4x for Leonardo DRS). Leonardo DRS offers the higher dividend yield (1.01% vs 0.85%). Leonardo DRS converts more of its revenue into profit, with a net margin of 7.6% versus 4.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRS | RRX |
|---|---|---|
| Share price | $35.78 | $164.17 |
| Market cap | $9.55B | $10.93B |
| 1-day change | -2.72% | -1.32% |
| YTD return | +4.96% | +17.00% |
| 1-year return | -19.99% | +14.04% |
| 5-year return | +248.39% | +13.81% |
| P/E ratio (TTM) | 30.07 | 33.78 |
| Forward P/E | 24.39 | 12.63 |
| EPS (TTM) | $1.19 | $4.86 |
| Dividend yield | 1.01% | 0.85% |
| Annual dividend | $0.36 | $1.40 |
| Revenue (latest FY) | $3.65B | $5.93B |
| Revenue growth (YoY) | +12.80% | -1.65% |
| Net income (latest FY) | $278.00M | $279.50M |
| Gross margin | 23.82% | 37.37% |
| Operating margin | 9.54% | 11.47% |
| Net margin | 7.62% | 4.71% |
| 52-week high | $50.59 | $247.80 |
| 52-week low | $32.43 | $127.96 |
| Distance from 52-week high | -29.27% | -33.75% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +50.42% | +47.41% |
| Average volume | 875.01K | 1.20M |
| Shares outstanding | 266.89M | 66.57M |
| Employees | 7,300 | 28,700 |
| Sector | Industrials | Industrials |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RRX has outperformed DRS by 34.0 percentage points over the past year.
- Leonardo DRS grew revenue faster in its latest fiscal year (+12.80% vs -1.65%).
About Leonardo DRS
DRS stock →Leonardo DRS, Inc., together with its subsidiaries, provides defense electronic products and systems, and military support services worldwide. It operates through Advanced Sensing and Computing and Integrated Mission Systems segments.
Industrials · Industrial Machinery/Components · 7,300 employees
About Regal Rexnord
RRX stock →Regal Rexnord Corporation provides sustainable solutions for power, transmit, and control motion products in the North America, Asia, Europe, and internationally. The company operates through Automation & Motion Control, Industrial Powertrain Solutions, and Power Efficiency Solutions.
Industrials · Industrial Machinery/Components · 28,700 employees
DRS vs RRX FAQ
Which is bigger, Leonardo DRS or Regal Rexnord?
Regal Rexnord (RRX) is larger, with a market capitalization of $10.93B compared with $9.55B for Leonardo DRS (DRS).
Which stock has performed better over the past year, DRS or RRX?
RRX returned +14.04% over the past 12 months, compared with -19.99% for DRS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DRS or RRX?
DRS has the lower trailing P/E at 30.1, versus 33.8 for RRX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Leonardo DRS or Regal Rexnord?
Leonardo DRS has the higher yield at 1.01%, compared with 0.85% for Regal Rexnord.
Are Leonardo DRS and Regal Rexnord in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.